These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2190800)

  • 1. Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-beta 1 in normal rat kidney (NRK) cells: decreased PAI-1 expression in transformed NRK cells.
    Newman MJ; Lane EA; Iannotti AM; Nugent MA; Pepinsky RB; Keski-Oja J
    Endocrinology; 1990 Jun; 126(6):2936-46. PubMed ID: 2190800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
    Jullien P; Berg TM; de Lannoy C; Lawrence DA
    J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
    Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
    Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.
    Laiho M; Saksela O; Keski-Oja J
    J Biol Chem; 1987 Dec; 262(36):17467-74. PubMed ID: 3121597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
    Boehm JR; Kutz SM; Sage EH; Staiano-Coico L; Higgins PJ
    J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the 52 kDa cytoskeletal-like protein of cytochalasin D-stimulated normal rat kidney (NRK/CD) cells as substrate-associated glycoprotein p52 [plasminogen-activator inhibitor type-1 (PAI-1)]. Expression of p52 (PAI-1) in NRK/CD cells is regulated at the level of mRNA abundance.
    Higgins PJ; Ryan MP
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):433-9. PubMed ID: 1599429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
    Newman MJ; Lane EA; Nugent MA; Racker E
    Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J; Koli K
    J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R; Lawrence DA; Jullien P
    Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen.
    Nugent MA; Newman MJ
    J Biol Chem; 1989 Oct; 264(30):18060-7. PubMed ID: 2553700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.
    Pfeilschifter J; Erdmann J; Schmidt W; Naumann A; Minne HW; Ziegler R
    Endocrinology; 1990 Feb; 126(2):703-11. PubMed ID: 2298166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of transforming growth factors by simian sarcoma virus-transformed cells.
    van Zoelen EJ; van Rooijen MA; van Oostwaard TM; de Laat SW
    Cancer Res; 1987 Mar; 47(6):1582-7. PubMed ID: 3028611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells.
    Fernandez-Pol JA; Hamilton PD; Klos DJ
    Cancer Res; 1982 Feb; 42(2):609-17. PubMed ID: 6275983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
    Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
    Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha.
    Myrdal SE; Twardzik DR; Auersperg N
    J Cell Biol; 1986 Apr; 102(4):1230-4. PubMed ID: 3007529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts.
    Overall CM; Wrana JL; Sodek J
    Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
    Cajot JF; Bamat J; Bergonzelli GE; Kruithof EK; Medcalf RL; Testuz J; Sordat B
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):6939-43. PubMed ID: 2169614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.